Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Normal Subjects”

4,275 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 4,275 results

Testing effectiveness (Phase 2)Ended earlyNCT00634933
What this trial is testing

Study Evaluating 2 Dosing Regimens Of TRU-015 In Rheumatoid Arthritis

Who this might be right for
Arthritis, Rheumatoid
Pfizer 222
Testing effectiveness (Phase 2)Study completedNCT00443326
What this trial is testing

AMG 714 20060349 Multiple Dose Study in Moderate to Severe Psoriasis Subjects

Who this might be right for
Psoriasis
Amgen 22
Testing effectiveness (Phase 2)Study completedNCT00301899
What this trial is testing

Trastuzumab and Pertuzumab in Treating Patients With Unresectable Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Previous Trastuzumab

Who this might be right for
Breast Cancer
National Institutes of Health Clinical Center (CC) 37
Early research (Phase 1)Study completedNCT04044898
What this trial is testing

Pharmacokinetics and Safety of ALA in Acne Vulgaris

Who this might be right for
Acne Vulgaris
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. 19
Early research (Phase 1)Study completedNCT01492647
What this trial is testing

JNJ 10229570-AAA to Evaluate Safety and Tolerability in Japanese Participants With Acne Vulgaris

Who this might be right for
Acne Vulgaris
Janssen Pharmaceutical K.K. 18
Testing effectiveness (Phase 2)Study completedNCT01451138
What this trial is testing

Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004541)

Who this might be right for
Androgenetic AlopeciaMale Pattern BaldnessFemale Pattern Baldness
Aderans Research Institute 40
Testing effectiveness (Phase 2)Study completedNCT03436615
What this trial is testing

Evaluate the Safety and Efficacy of SB206 in Subjects With Molluscum Contagiosum

Who this might be right for
Molluscum Contagiosum
Novan, Inc. 256
Large-scale testing (Phase 3)Study completedNCT00237887
What this trial is testing

Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Abbott 1,212
Early research (Phase 1)Study completedNCT02379793
What this trial is testing

Skin Irritation Test of LEO 80185 Gel in Healthy Japanese Subjects

Who this might be right for
Skin and Connective Tissue Diseases
LEO Pharma 33
Not applicableStudy completedNCT03391349
What this trial is testing

Quantification of Proteomes: L-plastin , Lipocalin and Adiponectin in Chronic Periodontitis and Diabetic Subjects

Who this might be right for
Periodontal Diseases
Meenakshi Ammal Dental College and Hospital 70
Early research (Phase 1)Study completedNCT02536911
What this trial is testing

The Effects of Hepatic Impairment on the Pharmacokinetics and Tolerability of Eliglustat Tartrate

Who this might be right for
Gaucher Disease
Genzyme, a Sanofi Company 24
Early research (Phase 1)Study completedNCT01632332
What this trial is testing

Vaccine Therapy in Treating Patients With Previously Treated Stage II-III HER2-Positive Breast Cancer

Who this might be right for
HER2-positive Breast CancerMale Breast CancerStage II Breast Cancer+3 more
Mayo Clinic 22
Early research (Phase 1)Study completedNCT02447393
What this trial is testing

Phase 1 Study of Levocetirizine

Who this might be right for
Dermatitis
GlaxoSmithKline 20
Large-scale testing (Phase 3)Study completedNCT03556358
What this trial is testing

Trial to Compare the Safety, Efficacy and Immunogenicity of TX05 With Herceptin® in HER2+ Early Breast Cancer

Who this might be right for
Breast CancerBreast NeoplasmsHER2-positive Breast Cancer+2 more
Tanvex BioPharma USA, Inc. 809
Testing effectiveness (Phase 2)Study completedNCT02656043
What this trial is testing

A Safety, Tolerability, Efficacy and Exposure Study of XEN801 Topical Gel

Who this might be right for
Acne Vulgaris
Xenon Pharmaceuticals Inc. 213
Not applicableEnrolling By InvitationNCT03755245
What this trial is testing

Biodistribution, Dosimetry and Performance of [68Ga]Ga-DOTA-Siglec-9 in Healthy and Patients With Rheumatoid Arthritis, Vasculitis or Pulmonary Sarcoidosis

Who this might be right for
Healthy SubjectsRheumatoid ArthritisVasculitis+1 more
Turku University Hospital 26
Testing effectiveness (Phase 2)Active Not RecruitingNCT04902872
What this trial is testing

Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid Tumors

Who this might be right for
Solid Tumor, AdultEpithelial Ovarian CancerSmall Cell Lung Carcinoma+9 more
Cybrexa Therapeutics 130
Large-scale testing (Phase 3)Study completedNCT03478787
What this trial is testing

Risankizumab Versus Secukinumab for Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
AbbVie 327
Not applicableLooking for participantsNCT00034216
What this trial is testing

Collection of Blood From Patients With Cancer

Who this might be right for
Prostate CancerBreast CancerColon Cancer+2 more
National Cancer Institute (NCI) 1,750
Post-approval studies (Phase 4)Not Yet RecruitingNCT07285863
What this trial is testing

Effect Of Secretin For In Injection (Chirostim) On Pancreatic Fluid Composition In Healthy Subjects

Who this might be right for
Exocrine Pancreatic InsufficiencyChronic Pancreatitis
Mayo Clinic 24
Load More Results